# FDA recall D-264-2013

> **Lupin Pharmaceuticals Inc.** · Class III · drug recall initiated 2013-01-31.

## Product

Suprax (cefixime for oral suspension) USP, 100 mg/5 mL, 50 mL bottles (when reconstituted), Manufactured for Lupin Pharmaceuticals, Inc. 111 South Calvert Street, Baltimore, MD 21202, Manufactured by Lupin Limited Mumbai 400 058 India, NDC 68180-202-03.

## Reason for recall

Discoloration; Product may not meet specifications for color description once reconstituted.

## Distribution

Nationwide

## Key facts

- **Recall number:** D-264-2013
- **Recalling firm:** Lupin Pharmaceuticals Inc.
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2013-01-31
- **Report date:** 2013-04-24
- **Termination date:** 2013-09-11

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Baltimore, MD, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-264-2013

## Citation

> AI Analytics. FDA recall D-264-2013. Retrieved 2026-05-26 from https://api.ai-analytics.org/recall/D-264-2013. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*